Advancing Privacy-Enhancing Technologies
The importance of data sharing and analytics to drive evidence-based decision making has been highlighted by data science consortia and researchers alike. In the highly competitive and innovative fields of health research and treatment development, solutions for data sharing and analytics must contend with data that include a large number of variables, have spatial and temporal dependence, and inconsistent or missing data (for example, due to non-response bias in surveys or complex data collection practices and linking challenges). Even static data is refactored and reharmonized to suit the various acrobatics of statistical analysis.
This paper provides an overview of the landscape of tools considered for privacy-enhancing data sharing and analytics. We highlight the needs and perspectives of different stakeholders involved in health services improvement and health research across the full lifecycle of data. While there are many privacy-enhancing tools, we focus our attention on the challenges of integration and interoperability, especially for complex health data and analytical pipelines, and the impact on end users striving to improve health outcomes. We believe that, in order to drive the adoption of safe, useful, and timely data and analytics at scale, there is an increasing need for the integration and deployment of suites of tools that are interoperable and complimentary.
Situation: California’s Consumer Privacy Act inspired Comcast to evolve the way in which they protect the privacy of customers who consent to share personal information with them.
Situation: Integrate.ai’s AI-powered tech helps clients improve their online experience by sharing signals about website visitor intent. They wanted to ensure privacy remained fully protected within the machine learning / AI context that produces these signals.
Situation: Novartis’ digital transformation in drug R&D drives their need to maximize value from vast stores of clinical study data for critical internal research enabled by their data42 platform.
Situation: CancerLinQ™, a subsidiary of American Society of Clinical Oncology, is a rapid learning healthcare system that helps oncologists aggregate and analyze data on cancer patients to improve care. To achieve this goal, they must de-identify patient data provided by subscribing practices across the U.S.
Situation: Needed to ensure the primary market research process was fully compliant with internal policies and regulations such as GDPR.
Situation: Needed to enable AI-driven product innovation with a defensible governance program for the safe and responsible use
of voice-to-text data under Shrems II.
This course runs on the 2nd Wednesday of every month, at 11 a.m. ET (45 mins). Click the button to register and select the date that works best for you.